Engel T - Search Results

1

Avila J, de Barreda EG, Fuster-Matanzo A, Simón D, Llorens-Martín M, Engel T, Lucas JJ, Díaz-Hernández M, Hernández F. Avila J, et al. Among authors: engel t. Biochem Soc Trans. 2012 Aug;40(4):653-5. doi: 10.1042/BST20120006. Biochem Soc Trans. 2012. PMID: 22817710 Review.

2

Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration.

Engel T, Lucas JJ, Gómez-Ramos P, Moran MA, Avila J, Hernández F. Engel T, et al. Neurobiol Aging. 2006 Sep;27(9):1258-68. doi: 10.1016/j.neurobiolaging.2005.06.010. Epub 2005 Jul 27. Neurobiol Aging. 2006. PMID: 16054268

3

Characterization of Alzheimer paired helical filaments by electron microscopy.

Hernández F, Engel T, Gómez-Ramos A, Pérez M, Avila J. Hernández F, et al. Among authors: engel t. Microsc Res Tech. 2005 Jul;67(3-4):121-5. doi: 10.1002/jemt.20194. Microsc Res Tech. 2005. PMID: 16103994 Review.

4

Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.

Engel T, Hernández F, Avila J, Lucas JJ. Engel T, et al. J Neurosci. 2006 May 10;26(19):5083-90. doi: 10.1523/JNEUROSCI.0604-06.2006. J Neurosci. 2006. PMID: 16687499 Free PMC article.

5

Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.

Engel T, Goñi-Oliver P, Lucas JJ, Avila J, Hernández F. Engel T, et al. J Neurochem. 2006 Dec;99(6):1445-55. doi: 10.1111/j.1471-4159.2006.04139.x. Epub 2006 Oct 24. J Neurochem. 2006. PMID: 17059563 Free article.

6

Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.

Hooper C, Markevich V, Plattner F, Killick R, Schofield E, Engel T, Hernandez F, Anderton B, Rosenblum K, Bliss T, Cooke SF, Avila J, Lucas JJ, Giese KP, Stephenson J, Lovestone S. Hooper C, et al. Among authors: engel t. Eur J Neurosci. 2007 Jan;25(1):81-6. doi: 10.1111/j.1460-9568.2006.05245.x. Eur J Neurosci. 2007. PMID: 17241269

7

A mouse model to study tau pathology related with tau phosphorylation and assembly.

Engel T, Lucas JJ, Hernández F, Avila J. Engel T, et al. J Neurol Sci. 2007 Jun 15;257(1-2):250-4. doi: 10.1016/j.jns.2007.01.047. Epub 2007 Mar 23. J Neurol Sci. 2007. PMID: 17362999

8

Lithium, a potential protective drug in Alzheimer's disease.

Engel T, Goñi-Oliver P, Gómez de Barreda E, Lucas JJ, Hernández F, Avila J. Engel T, et al. Neurodegener Dis. 2008;5(3-4):247-9. doi: 10.1159/000113715. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322403 Review.

9

Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.

Engel T, Goñi-Oliver P, Gomez-Ramos P, Morán MA, Lucas JJ, Avila J, Hernández F. Engel T, et al. Neuroscience. 2008 Dec 10;157(4):772-80. doi: 10.1016/j.neuroscience.2008.09.047. Epub 2008 Oct 4. Neuroscience. 2008. PMID: 18951953

10

Tau kinase I overexpression induces dentate gyrus degeneration.

Avila J, Gómez de Barreda E, Engel T, Pérez M, Martín-Maestro P, Fuster-Matanzo A, Goñi-Oliver P, Lucas JJ, Hernández F. Avila J, et al. Among authors: engel t. Neurodegener Dis. 2010;7(1-3):13-5. doi: 10.1159/000283476. Epub 2010 Feb 13. Neurodegener Dis. 2010. PMID: 20160451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

453 results

Search Page